A Rare Incidence of Ethambutol Induced Toxic Optic Neuropathy

Mousigan, M. V. and Nissi, L. and Sreenivasan, V. (2023) A Rare Incidence of Ethambutol Induced Toxic Optic Neuropathy. International Journal of Medical and Pharmaceutical Case Reports, 16 (1). pp. 1-5. ISSN 2394-109X

[thumbnail of 322-Article Text-621-1-10-20230120.pdf] Text
322-Article Text-621-1-10-20230120.pdf - Published Version

Download (345kB)

Abstract

Ethambutol induces toxic optic neuropathy (EON), which most typically presents as bilateral symmetrical loss of vision and, due to a lack of early detection and adequate treatment, often causes serious irreversible visual impairment. EON is time and dose dependent. In this case report, we will discuss a 59-year-old female patient who came in with complaints of visual impairment, inclusive of a colour vision defect (dyschromatopsia) and blurred vision (scotoma). Her past medication history includes use of first-line anti-tubercular therapy (ATT) with four drugs: Rifampicin, Isoniazid, Ethambutol, and Pyrazinamide. Pyrazinamide was taken for two months, and other medications (Rifampicin, Isoniazid, and Ethambutol) were taken for a period of seven months. From this case report, we will get a clear picture necessitating continuous monitoring for ocular toxicity.

Item Type: Article
Subjects: Open Library Press > Medical Science
Depositing User: Unnamed user with email support@openlibrarypress.com
Date Deposited: 21 Jan 2023 12:48
Last Modified: 21 Jan 2023 12:48
URI: https://openlibrarypress.com/id/eprint/349

Actions (login required)

View Item
View Item